Back
Akero Therapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
AKRO
Akero Therapeutics
Last Price:
$28.92
Seasonality Move:
-9.11%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Akero Therapeutics Stock Forecast
-
Over the next 52 weeks, Akero Therapeutics has on average historically risen by 24% based on the past 5 years of stock performance.
-
Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Akero Therapeutics Stock Undervalued?The current Akero Therapeutics [AKRO] share price is $28.56. The Score for AKRO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Akero Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Akero Therapeutics has on average historically risen by 24% based on the past 5 years of stock performance.
Akero Therapeutics Stock Rating
Sell
28
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics overpriced?
-
Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Akero Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com
52-Week Data
52-Week High:
37.00
52-Week Low:
15.32
Prediction Charts
Market Cap:
2B
Price in USD:
28.56
Volume:
266.4K
Beta:
-0.27
Technical Analysis
SMA50:
30.77
SMA100:
28.73
SMA200:
25.89
52-Wk Change:
23.74%
Stock Predictions
-
Is Akero Therapeutics stock public?Yes, Akero Therapeutics is a publicly traded company.
-
What is the Akero Therapeutics stock quote today?The Akero Therapeutics stock price is 28.56 USD today.
-
How to buy Akero Therapeutics stock online?You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-5 | 30.75 | 29.70 | 31.06 | 29.58 |
| Dec-6 | 29.76 | 31.11 | 31.34 | 29.58 |
| Dec-9 | 31.54 | 31.12 | 31.90 | 30.67 |
| Dec-10 | 30.79 | 30.64 | 31.15 | 29.97 |
| Dec-11 | 30.99 | 30.35 | 30.99 | 30.08 |
| Dec-12 | 30.18 | 29.03 | 30.54 | 28.93 |
| Dec-13 | 28.55 | 28.89 | 29.26 | 28.25 |
| Dec-16 | 28.90 | 29.23 | 29.57 | 28.47 |
| Dec-17 | 29.10 | 30.61 | 31.41 | 28.45 |
| Dec-18 | 30.66 | 28.76 | 30.66 | 27.82 |
| Dec-19 | 28.59 | 28.40 | 29.05 | 27.35 |
| Dec-20 | 28.09 | 29.34 | 29.77 | 28.09 |
| Dec-23 | 29.79 | 28.37 | 29.79 | 27.80 |
| Dec-24 | 28.40 | 28.56 | 28.79 | 28.02 |
Akero Therapeutics Earnings
Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Akero Therapeutics Forecast Revenue Growth
Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.